5 days agoINSIGHTSCommon Misconceptions About Patent RightsCommon misconceptions about patent rights: In my decades of counseling life sciences companies, I have found that many inventors and...
Oct 3INSIGHTSFTO - When Is It Time?When should we assure we have FTO for our private biotech company? Summary: FTO for a private biotech company is typically a multi-stage...
Sep 18INSIGHTS101 Rejection Trends Over the Past Years101 rejections at the USPTO plummeted in computational biology in 2023! We analyzed office actions since 2008 related to...
Aug 28PROCESS EXCELLENCEExtended Patent Family Buildout - 3 Key Zones of OpportunityINTRODUCTORY COMMENTS RE: BIOTECH/PHARMA EXTENDED PATENT FAMILIES In complex art areas like biotech/biopharma, patent strategy is about...
Jul 29, 2023INSIGHTSThe AMRN story - Value of U.S. Biopharma PatentsThe $AMRN/Vascepa story... A sad 🥲 but insightful🤔 story about the value of U.S. biopharma patents From ~$23/share to ~$1/share in ~5...
Jul 4, 2023INSIGHTSFDA/USPTO Web Sites List Patent Term Extension (PTE) Applications & GrantsIf you are interested in learning more about prior patent term extension filings, the USPTO and FDA provide some helpful links, which are...
Mar 25, 2023INSIGHTSAmgen v. Sanofi - Biotech Enablement - Sup Ct. Oral Args TomorrowMarch 26, 2023 The U.S. Supreme Court will hear oral arguments tomorrow in Amgen v. Sanofi, an important biotech enablement case. The...